Pharmacoeconomic Assessment in Nabi-4514 and Nabi-4515 Phase 3 Studies

Completed · Phase 3 · Has a placebo group

Conditions studied: Smoking Cessation

In brief

The purpose of this study is to look at pharmacoeconomic data for subjects that have received either NicVAX or placebo in the Nabi-4514 or Nabi-4515 studies.

Key facts

Study ID

NCT01178346

Run by

Nabi Biopharmaceuticals

People needed

500

Starts

2010-07-01

Expected to finish

2011-11-01

Last updated by the study team

2012-05-09

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects who are eligible for randomization or have not reached Week 12 in Nabi-4514 or Nabi-4515 studies.
• Subjects who agree to participate in health-related quality of life study.

You may not qualify if…

• Subjects who are unable to complete a HRQoL questionnaire because of inability to understand the language or due to mental impairment.

Where it is running

• NicVAX Investigator — Tucson, Arizona, United States
• NicVAX Investigator — Encino, California, United States
• NicVAX Investigator — Los Alamitos, California, United States
• NicVAX — Newport Beach, California, United States
• NicVAX Investigator — San Diego, California, United States
• NicVAX Investigator — Denver, Colorado, United States
• NicVAX Investigator — Brooksville, Florida, United States
• NicVAX Investigator — Orlando, Florida, United States
• NicVAX Investigator — St. Petersburg, Florida, United States
• NicVAX Investigator — Tampa, Florida, United States
• NicVAX Investigator — Boise, Idaho, United States
• NicVAX — Indianapolis, Indiana, United States
• NicVAX Investigator — Metarie, Louisiana, United States
• NicVAX Investigator — Baltimore, Maryland, United States
• NicVAX Investigator — Minneapolis, Minnesota, United States
• NicVAX Investigator — Rochester, Minnesota, United States
• NicVAX Investigator — Omaha, Nebraska, United States
• NicVAX Investigator — Buffalo, New York, United States
• NicVAX Investigator — Cincinnati, Ohio, United States
• NicVAX Investigator — Mt. Pleasant, South Carolina, United States
• NicVAX Investigator — Nashville, Tennessee, United States
• NicVAX Investigator — Salt Lake City, Utah, United States
• NicVAX Investigator — Salt Lake City, Utah, United States
• NicVAX Investigator — Seattle, Washington, United States
• NicVAX Investigator — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.